Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover trial of oral versus rectal immediate-release morphine for cancer breakthrough pain
ChiCTR1900021701Phase 2Not yet recruiting
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of morphine in breakthrough pain and cancer pain (2 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Efficacy and Onset of analgesic effect. Planned start Apr 2019; status: not yet recruiting.
02
Drugs
morphine
03
Conditions
breakthrough paincancer pain
Beyond the preview
Go deeper on ChiCTR1900021701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021701.